Does Obesity Protect Against Death in Sepsis? A Retrospective Cohort Study of 55,038 Adult Patients.


Journal

Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 23 2 2019
medline: 18 2 2020
entrez: 22 2 2019
Statut: ppublish

Résumé

Observational studies suggest obesity is associated with sepsis survival, but these studies are small, fail to adjust for key confounders, measure body mass index at inconsistent time points, and/or use administrative data to define sepsis. To estimate the relationship between body mass index and sepsis mortality using detailed clinical data for case detection and risk adjustment. Retrospective cohort analysis of a large clinical data repository. One-hundred thirty-nine hospitals in the United States. Adult inpatients with sepsis meeting Sepsis-3 criteria. Body mass index in six categories: underweight (body mass index < 18.5 kg/m), normal weight (body mass index = 18.5-24.9 kg/m), overweight (body mass index = 25.0-29.9 kg/m), obese class I (body mass index = 30.0-34.9 kg/m), obese class II (body mass index = 35.0-39.9 kg/m), and obese class III (body mass index ≥ 40 kg/m). Multivariate logistic regression with generalized estimating equations to estimate the effect of body mass index category on short-term mortality (in-hospital death or discharge to hospice) adjusting for patient, infection, and hospital-level factors. Sensitivity analyses were conducted in subgroups of age, gender, Elixhauser comorbidity index, Sequential Organ Failure Assessment quartiles, bacteremic sepsis, and ICU admission. From 2009 to 2015, we identified 55,038 adults with sepsis and assessable body mass index measurements: 6% underweight, 33% normal weight, 28% overweight, and 33% obese. Crude mortality was inversely proportional to body mass index category: underweight (31%), normal weight (24%), overweight (19%), obese class I (16%), obese class II (16%), and obese class III (14%). Compared with normal weight, the adjusted odds ratio (95% CI) of mortality was 1.62 (1.50-1.74) for underweight, 0.73 (0.70-0.77) for overweight, 0.61 (0.57-0.66) for obese class I, 0.61 (0.55-0.67) for obese class II, and 0.65 (0.59-0.71) for obese class III. Results were consistent in sensitivity analyses. In adults with clinically defined sepsis, we demonstrate lower short-term mortality in patients with higher body mass indices compared with those with normal body mass indices (both unadjusted and adjusted analyses) and higher short-term mortality in those with low body mass indices. Understanding how obesity improves survival in sepsis would inform prognostic and therapeutic strategies.

Identifiants

pubmed: 30789403
doi: 10.1097/CCM.0000000000003692
pmc: PMC6465121
mid: NIHMS1518916
doi:

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

643-650

Subventions

Organisme : AHRQ HHS
ID : K08 HS025008
Pays : United States
Organisme : Intramural NIH HHS
ID : Z99 CL999999
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA CL090045-02
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Références

Crit Care. 2013 Jun 20;17(3):R122
pubmed: 23786836
BMC Health Serv Res. 2015 Sep 15;15:384
pubmed: 26373538
Clin Nutr. 1997 Mar;16 Suppl 1:11-7
pubmed: 16844616
Crit Care Med. 2015 Dec;43(12):2693-4
pubmed: 26575664
JAMA. 2017 Oct 3;318(13):1241-1249
pubmed: 28903154
Anesthesiology. 2011 Apr;114(4):912-7
pubmed: 21427539
BMC Infect Dis. 2013 Aug 16;13:377
pubmed: 23957291
J Crit Care. 2013 Dec;28(6):964-9
pubmed: 23948146
JAMA. 2013 Oct 16;310(15):1591-600
pubmed: 24108501
Lancet Respir Med. 2017 Oct;5(10):816-826
pubmed: 28864056
J Clin Endocrinol Metab. 2004 Jun;89(6):2548-56
pubmed: 15181022
Am Heart J. 2008 Jul;156(1):13-22
pubmed: 18585492
N Engl J Med. 2014 Jan 16;370(3):233-44
pubmed: 24428469
Crit Care. 2014 Jan 13;18(2):R12
pubmed: 24410863
Trends Mol Med. 2014 Apr;20(4):195-203
pubmed: 24581450
Shock. 2016 Apr;45(4):349-58
pubmed: 26513706
Crit Care Med. 2014 Aug;42(8):1766-74
pubmed: 24717466
Crit Care. 2016 Jun 15;20(1):181
pubmed: 27306751
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Eur J Epidemiol. 2014 Nov;29(11):801-12
pubmed: 25354991
J Crit Care. 2014 Oct;29(5):887.e1-5
pubmed: 24997725
Eur J Endocrinol. 2003 Aug;149(2):129-35
pubmed: 12887290
Crit Care Med. 2015 Jan;43(1):87-100
pubmed: 25289931
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Intensive Care Med. 2009 Jul;35(7):1152-70
pubmed: 19189078
Obesity (Silver Spring). 2008 Mar;16(3):515-21
pubmed: 18239602
Ann N Y Acad Sci. 2013 Mar;1278:1-10
pubmed: 23488557
Crit Care Med. 2008 Jan;36(1):151-8
pubmed: 18007266
Intensive Care Med. 2011 Nov;37(11):1793-9
pubmed: 21818652
Lancet. 2016 Aug 20;388(10046):776-86
pubmed: 27423262
Obesity (Silver Spring). 2007 Jul;15(7):1886-94
pubmed: 17636108
Crit Care Med. 2015 Dec;43(12):2623-32
pubmed: 26427591
BMC Anesthesiol. 2017 Aug 31;17(1):118
pubmed: 28859605
Ann Am Thorac Soc. 2013 Apr;10(2):81-9
pubmed: 23607835
Am J Clin Nutr. 2004 Apr;79(4):613-8
pubmed: 15051605
Crit Care. 2013 Apr 17;17(2):R72
pubmed: 23594407
Wien Klin Wochenschr. 2010 Jan;122(1-2):31-6
pubmed: 20177857
Crit Care Med. 2017 Mar;45(3):e331
pubmed: 28212233
BMC Infect Dis. 2007 Mar 09;7:13
pubmed: 17349033
Crit Care Med. 2013 Aug;41(8):1878-83
pubmed: 23685638
Intensive Care Med. 2008 Nov;34(11):1999-2009
pubmed: 18670756
BMC Geriatr. 2018 Feb 6;18(1):42
pubmed: 29409463
BMC Anesthesiol. 2017 Oct 25;17(1):147
pubmed: 29070011
Lancet. 2017 Jun 10;389(10086):2284
pubmed: 28612743
Intern Emerg Med. 2015 Jun;10(4):471-9
pubmed: 25647585
Kidney Int. 1999 Apr;55(4):1560-7
pubmed: 10201023
J Crit Care. 2015 Jun;30(3):518-24
pubmed: 25575851
JAMA Cardiol. 2018 Apr 1;3(4):280-287
pubmed: 29490333

Auteurs

Dominique J Pepper (DJ)

Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD.

Cumhur Y Demirkale (CY)

Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD.

Junfeng Sun (J)

Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD.

Chanu Rhee (C)

Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, MA.
Department of Medicine, Brigham and Women's Hospital, Boston, MA.

David Fram (D)

Commonwealth Informatics, Waltham, MA.

Peter Eichacker (P)

Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD.

Michael Klompas (M)

Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, MA.
Department of Medicine, Brigham and Women's Hospital, Boston, MA.

Anthony F Suffredini (AF)

Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD.

Sameer S Kadri (SS)

Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH